FDA approves Roche’s Vabysmo prefilled syringe for eye diseases, expanding treatment options for millions
Roche (SIX: RO, ROG; OTCQX: RHHBY), a global leader in pharmaceuticals and diagnostics, announced a significant advancement in eye care with the U.S. Food and Drug Administration’s (FDA) approval of the Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS). This new formulation is approved for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD), […]